A successful ENT and a board-certified dermatologist took their talents to develop manufacture, and market prescription and OTC drug products that maintain and restore mucosal and skin integrity. These nasal sprays and mouth sprays are the must have products for consumers to arm themselves and combat viruses, bacteria and provide another layer of protection against COVID-19.
Dr. Francis Parnell, a practicing Otolaryngology-Head and Neck ( ENT) Surgeon for over 30 years is Chairman and C.E.O. of Parnell Pharmaceuticals, the pharmaceutical company he co-founded with his wife Dr. Diana Parnell. Diana Parnell is a board-certified dermatologist with extensive experience and expertise in cosmetic and laser surgery as well as general dermatology and head of Cosmetic and Laser Surgery Institute Kentfield, CA. They worked together to develop Cosmetic and Laser Surgery Institute and together the couple bring years of consumer health experience, treating patients and developing oral, nasal and personal care products so that consumers could have options to….
Parnell Pharmaceuticals announced the development of the topical nasal spray caked Nomovid. Nomovid is based upon a substance licensed by Parnell from New Mexico Tech University to treat drug-resistant bacteria and fungi such as MRSA and Candida auris.
“Since it breaks down lipids in the viral envelope, we tested it against the novel coronavirus” says Dr. Francis Parnell, Chairman and C.E.O. of Parnell Pharmaceuticals. “An independent, outside laboratory has confirmed our findings and found it to be greater than 99.9% effective in vitro against the SARS-CoV-2 virus,”
Parnell’s newest product Mouth Kote-MD Mouth Spray is with patented MycoDelens and Natural Yerba Santa and has been shown with in vitro laboratory testing to be an effective antiseptic against Antimicrobial Resistant (AMR) pathogens including bacteria, fungi, and coronaviruses such as the SARS-CoV-2 virus. Mouth Kote-MD is an excellent pre-rinse before dental exams to help prevent COVID-19 and in addition it helps restore enamel.
Bio of Francis Parnell, M.D., CEO of Parnell Pharmaceuticals
Dr. Francis Parnell is CEO of Parnell Pharmaceuticals a California based private pharmaceutical company founded in 1986. The company develops, manufactures, and markets prescription and OTC drug products that maintain and restore mucosal and skin integrity. The products are natural-based and patented for oral and nasal care and personal care.
Parnell co-founded Parnell Pharmaceuticals and Y.S. Laboratories over thirty years ago to research and create pharmaceuticals to sustain wellness and to improve quality of life. A graduate of Georgetown University School of Medicine Parnell completed residency training at the University of Wisconsin at Madison.
Parnell was a practicing Otolarygology-Head and Neck ( ENT) Surgeon for over 30 years. He is a Fellow, American Academy of Otolaryngology-Head and Neck Surgery and the American College of Surgeons. He is a co-founder of the Cosmetic & Laser Surgery Institute with wife Dr. Diana Parnell and previously was Corporate Medical Director at Becton, Dickinson Co. {B-D).
Parnell is the first company dedicated to the research and development of new and innovative products to restore and maintain mucosal integrity. Employing a proprietary and patented technology, Parnell Pharmaceuticals’ products contain Yerba Santa, which contains natural anti-oxidants, mucopolysaccharides, and glycoproteins.
Parnell Pharmaceuticals, Inc. is a closely held, private pharmaceutical company founded in 1986 and headquartered in San Rafael, California with an office in Dublin, Ireland. The company develops, manufactures, and markets prescription and OTC drug products that maintain and restore mucosal and skin integrity. The products are natural-based and patented for oral and nasal care, personal care, and anti-infective use. Parnell products are marketed and distributed in North America and Europe. https://www.parnellpharm.com/about
